← Back to Clinical Trials
Recruiting NCT05981482

NCT05981482 Visual Perception Difficulties After Stroke

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05981482
Status Recruiting
Phase
Sponsor Durham University
Condition Stroke
Study Type OBSERVATIONAL
Enrollment 200 participants
Start Date 2023-06-20
Primary Completion 2024-08-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
OxVPS

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 200 participants in total. It began in 2023-06-20 with a primary completion date of 2024-08-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this observational study is to learn how well the Oxford Visual Perception Screening (OxVPS) tool can identify stroke survivors with visual perception difficulties. The main aim is to determine the accuracy and utility of the OxVPS compared to the current gold standard assessment in stroke survivors. In other words, how well can the Oxford Visual Perception Screening tool (OxVPS) identify stroke patients with visual perception problems? Participants will completed the OxVPS and the current gold standards visual perception screening tool.

Eligibility Criteria

Inclusion Criteria: * Patients with a clinical diagnosis of stroke (ischemic stroke and/or intracerebral haemorrhage). * Within 6 weeks of confirmed stroke. Exclusion Criteria: * Insufficient understanding of English * Clinical concerns that patient is unable follow simple instructions. * Clinical concerns that patient is unable to concentrate for 15 minutes. * No capacity to provide informed consent.

Contact & Investigator

Central Contact

Kate Cowen, PhD

✉ kate.cowen@durham.ac.uk

📞 441913343275

Principal Investigator

Kathleen Vancleef, PhD

PRINCIPAL INVESTIGATOR

Durham University

Frequently Asked Questions

Who can join the NCT05981482 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05981482 currently recruiting?

Yes, NCT05981482 is actively recruiting participants. Contact the research team at kate.cowen@durham.ac.uk for enrollment information.

Where is the NCT05981482 trial being conducted?

This trial is being conducted at Abingdon, United Kingdom, Bishop Auckland, United Kingdom, Gateshead, United Kingdom.

Who is sponsoring the NCT05981482 clinical trial?

NCT05981482 is sponsored by Durham University. The principal investigator is Kathleen Vancleef, PhD at Durham University. The trial plans to enroll 200 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology